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ABSTRACT
Simultaneous calcified fibrous pseudotumor (CFT) and Castleman disease (CD) is an extremely rare association. CD is 
an uncommon lymphoproliferative disease that can arise in various sites of the body, while CFT is a rare type of benign 
fibrous lesion that frequently affects children and young adults, occurring as solitary or multiple lesions throughout the 
human body. Both entities are rare and exhibit typical and diverse histomorphological features. We report the case of a 
15-year-old female patient, who, at the age of 13 had a biopsy performed at an external medical center; however, after 
4 months the lesion had regrown. This lesion was removed with a surgical operation; however, it regrew 2 years later and 
was removed a third time. The results of the latter two biopsies were the same: CFT accompanying CD. The histologic 
examination of the excised lymph node and the surrounding tissue showed hyalinized fibrous tissue containing dystrophic 
and psammomatous calcification. In this case, the hyaline vascular type of CD was found to be intertwined with a CFT, 
which hampered the differentiation of whether both entities emerged within the lymph node or if the CFT developed 
from the soft tissue and then involved the lymph node. Future studies involving larger case series will provide a more 
precise insight, which should serve to resolve the current uncertainty. 
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INTRODUCTION
Calcified fibrous pseudotumor (CFT) is rare type 
of benign fibrous lesion, which was first described in 
1988 by Rosenthal and Abdul-Karim.1 CFT has been 
diagnosed in different age groups and in various 
localizations.2
The term “Castleman disease” has its origins in 
a case report published in 1954 by the pathologist 
Dr. Benjamin Castleman. It is a rare, benign disease 
of unknown etiology. This initial case report was 
soon followed by more detailed analysis of patients 
having isolated mediastinal lymphadenopathy.3 
Keller et al.4 defined two distinct clinicopathological 
variants of CD, namely the hyaline vascular type (HV) 
and the plasma cell type (PC). The disease presents 
clinically as unicentric or multicentric in nature.3
In this report, a case of CFT accompanied by CD 
is presented. To the best of our knowledge, our case is 
only the fifth report in the English literature to describe 
an association between these two entities.5
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CASE REPORT
A 15-year-old girl sought the Pediatric Surgery 
Clinic complaining of a non-tender, slow-growing 
mass on her right supraclavicular fossa, which, on the 
physical examination revealed to be enlarged lymph 
nodes, which were hard and immobile (Figure 1).
Her past medical history included an adenoidectomy 
at the age of 13 years due to a cleft palate and a 
nasopharyngeal stricture. A supraclavicular lymph node 
lesion was diagnosed, and a biopsy was performed at 
the external center; however, the patient revisited the 
center 4 months later with a regrowth of the lesion. 
This was surgically removed, but 2 years later the 
lesion had regrown and was surgically removed for 
the third time.
Histology results revealed the diagnosis of CD 
associated with CFT. The patient’s physical examination 
was normal except for the bulging mass over the 
supraclavicular fossa. Considering her past history, the 
working diagnosis was a relapse of the CD. Therefore, 
another surgical procedure was undertaken to remove 
the new tumor, which measured 5 × 5 × 2.5 cm. At this 
time, the histopathological findings of the lymph 
node sections showed increased lymphoid follicles 
and atretic germinal centers, as well as a proliferation 
of the internal and external vessels inside and outside 
the follicles. A concentric mantle zone consisting of 
small lymphocytes was observed around the follicles 
(Figures 2 and 3).
The histochemical and immunohistochemical 
examination showed the tumor cells of the CFT 
component staining focally with SMA and CD34, 
while the collagen fibers were stained diffusively 
with Masson’s trichrome (Figure 4). The tumor cells 
diffusively expressed vimentin, the plasma cells CD38, 
the histiocytes CD68, the endothelium CD31, the mast 
cells stained with Toluidine Blue, and the connective 
tissue with PAS. EMA, ALK, Elastic stain, and Congo red 
were negative. The morphological, histochemical, and 
immunohistochemical findings altogether supported 
the diagnosis of CFT associated with CD.Figure 1. Gross view of the surgical specimen.
Figure 2. Photomicrography of the lymph node. A – Castleman disease (CD) intertwined with calcified fibrous 
pseudotumor (CFT) (H&E, 20X); B – CFT with collagen fibers, lymphoid cells, and calcifications can be seen (arrows) 
(H&E, 100X).
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DISCUSSION
CD, also known as angiofollicular lymph node 
hyperplasia, is an uncommon lymphoproliferative 
disorder, which may involve the salivary glands, lung, 
pancreas, larynx, parotid gland, meninges, and even 
the limb muscles.6
C l in i ca l  va r i an t s  o f  CD a re  un i cen t r i c , 
multicentric, human herpes virus 8 (HHV8)-positive 
CD and thrombocytopenia, ascites/anasarca, 
myelofibrosis/fever, renal dysfunction/reticulin fibrosis, 
and organomegaly (TAFRO) syndrome. In unicentric 
CD, the lymph nodes are significantly enlarged and 
have histopathologic features of the hyaline-vascular 
variant (90%). Marked plasmacytosis is rarely seen 
(10%). In multicentric CD, patients typically present 
with diffuse lymphadenopathy. There are two common 
histologic patterns identified: Hypervascular and 
Figure 3. Photomicrography of the lymph node showing 
the Castleman disease with the vessels at the germinal 
centers (asterisk), concentric lymphoid zone around 
the follicle (arrow), accompanied by a calcified fibrous 
pseudotumor focus (H&E, 100X, CFT; Calcified fibrous 
tumors, CD; Castleman Disease).
Figure 4. Photomicrography of the lymph node. A – Calcifying fibrous tumor (CFT) and Castleman disease (CD) 
(Masson Trichrome, 400X); B – Arrow, focal staining in the CD tumor cells (CD34 staining, 200X); C – Arrow, focal 
staining in the CFT tumor cells (SMA stain, 400X).
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plasmacytic variant. The plasmacytic variant is most 
commonly seen in multicentric CD and is characterized 
by the prominence of interfollicular plasma cells within 
the lymph node. By immunohistochemistry, the plasma 
cells in multicentric Castleman disease are typically 
polytypic with respect to immunoglobulin light chain 
expression. Multicentric CD is seen in the dysregulation 
of interleukin (IL)-6 (increased) or other cytokines, 
such as vascular endothelial growth factor, IL-1, 
tumor necrosis factor-α. The syndrome of TAFRO is a 
recently described variant of idiopathic HHV8-negative 
multicentric Castleman disease. In this variant, there 
are similar clinicopathologic features to that of 
idiopathic multicentric Castleman disease. TAFRO 
typically performed to evaluate thrombocytopenia 
show megakaryocytic hyperplasia with clustering in a 
background of diffuse reticulin fibrosis. HHV8-positive 
CD is similar to multicentric CD in clinicopathologic 
features. In contrast, in HHV8-positive CD the lambda 
light chain restricted plasmablasts present within 
mantle zones.3
The characteristic finding of hyaline vascular 
type CD is the abnormal proliferation of dendritic 
cells in the follicles. The plasma cell type of CD may 
be accompanied by fever, anemia, and a decrease in 
hypergammaglobulinemia following the excision of the 
lesions. In addition, polyclonal plasma cells are found 
in the lymph nodes.7
CFT is a rare type of benign fibrous lesion that 
typically affects children and young adults, and involves 
the gastrointestinal tract, pleura, peritoneum, and 
mesentery, together with the deep and superficial soft 
tissues of the body.8
In 1988, Rosenthal and Abdul-Karim1 first 
described CFT as a “childhood fibrous tumor with 
psammoma bodies.”
In 1993, Fetch et al.2 named it as CFT. This entity 
emerges as a slow-growing, painless, subcutaneous or 
deeply located mass that is microscopically seen as a 
benign fibrous tumor with well-defined borders and 
unencapsulated, hyalinized, and fibrosclerotic tissue, 
including lymphocytes and plasma cells at various 
ratios. Characteristically, focal or diffuse dystrophic 
and frequently psammomatous calcifications are seen.9
There are few studies that report the association of 
CD and CFT. A stroma-rich variant of hyaline-vascular 
CD is described, which shows the over growth of a 
variety of stromal cells with predominantly vascular 
components and fibrosis in more than 50% of the 
lesion. These morphological features presented by 
this variant can be a differential diagnosis with CFT.10 
A rare case of HV-CD with angiomatous lymphoid 
hyperplasia, collagenization, and focal calcification was 
previously described.5 However, our case was typical 
of both lesions.
The HV-CD type also has been found to be 
a localized lesion supporting CFT characteristics. 
A l though  some CFT  cases  have  shown CD 
modifications, which suggests lymphoid tissue 
involvement, CFT formation in the HV-CD type is 
extremely rare.11 Valladolid et al.12 reported a case in 
which a mass had to be surgically removed because of 
an ileocolic intussusception with associated mesenteric 
lymphadenopathy. The mass was found to be a 
poor-cell CFT including lymph nodes with significant 
vascularity, atretic follicles, and histomorphological 
CD-specific findings.
The number of articles describing the association 
of CD and CFT is very low.5 Dargent et al.11 reported 
a HV-CD type associated with CFT in an inguinal 
lymphadenopathy case.
Although CD primarily involves the lymphatic 
system, it can also involve the extra lymphatic organs. 
However, CFT is not seen in the lymphatic system, 
but rather involves the soft tissues. Both of these rare 
diseases have typical histomorphological findings. 
In the present case, the HV type of CD involving the 
lymph node was found to be interwoven with the soft 
tissue, which rendered uncertainty as to whether the 
CFT first developed in the soft tissue and then invaded 
the lymph node, or vice versa.
The causes of both diseases remain unclear. 
Although there have been no findings in isolated 
CD indicating the presence of CFT, in advanced 
cases the stromal overreaction may display a CFT-like 
histomorphological appearance. In isolated CFT cases, 
along with the mild inflammation of the surrounding 
tissue, there has been no follicle hyperplasia or 
hyalinization of the follicle veins indicating CD. These 
diseases are hence considered to be two different 
entities.
In conclusion, although there have been very few 
reports on the coexistence of CD and CFT, the HV type 
of CD with stromal overreaction has been reported by 
Harmankaya I, Ugras NS, Sekmenli T, Demir F, Köksal Y
5-5Autops Case Rep (São Paulo). 2018;8(3):e2018033
some researchers to be a different variant.5 Further 
studies involving larger case series will provide a clearer 
insight, which should serve to resolve the current 
uncertainty in this regard.
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